OBJECTIVES: This study was conducted to determine the incidence of early stasis in radioembolization using resin yttrium-90 (Y-90) microspheres, to evaluate potential contributing factors, and to review initial imaging outcomes. METHODS: Patients in whom early stasis occurred were compared with those in whom complete delivery was achieved for tumour type and vascularity, tumour : normal liver ratio (T : N ratio) at technetium-99m-macroaggregated albumin (Tc-99m-MAA) angiography, previous intra-arterial therapy, and infusion site (left, right or whole liver). Tumour response was evaluated at 3 months and defined according to whether a partial response and stable disease versus progressive disease were demonstrated. RESULTS: A total of 71 patients underwent 128 Y-90 infusions in which 26 (20.3%) stasis events occurred. Hypervascular and hypovascular tumours had similar rates of stasis (17.4% versus 27.8%; P = NS). The mean ± standard deviation T : N ratio was 3.03 ± 1.54 and 3.66 ± 2.79 in patients with and without stasis, respectively (P = NS). Stasis occurred in 14 of 81 (17.3%) and 12 of 47 (25.5%) infusions following previous intra-arterial therapy and in therapy-naïve territories, respectively (P = NS). Early stasis occurred in 15 of 41 (36.6%) left, 10 of 65 (15.4%) right and one of 22 (4.5%) whole liver infusions (P < 0.001). Rates of partial response and stable disease were similar in the stasis (88.3%) and non-stasis (76.0%) groups (P = NS). CONCLUSIONS: Early stasis occurred in approximately 20% of infusions with similar incidences in hyper- and hypovascular tumours. Whole-liver therapy reduced the incidence of stasis. Stasis did not appear to affect initial imaging outcomes.
OBJECTIVES: This study was conducted to determine the incidence of early stasis in radioembolization using resin yttrium-90 (Y-90) microspheres, to evaluate potential contributing factors, and to review initial imaging outcomes. METHODS:Patients in whom early stasis occurred were compared with those in whom complete delivery was achieved for tumour type and vascularity, tumour : normal liver ratio (T : N ratio) at technetium-99m-macroaggregated albumin (Tc-99m-MAA) angiography, previous intra-arterial therapy, and infusion site (left, right or whole liver). Tumour response was evaluated at 3 months and defined according to whether a partial response and stable disease versus progressive disease were demonstrated. RESULTS: A total of 71 patients underwent 128 Y-90 infusions in which 26 (20.3%) stasis events occurred. Hypervascular and hypovascular tumours had similar rates of stasis (17.4% versus 27.8%; P = NS). The mean ± standard deviation T : N ratio was 3.03 ± 1.54 and 3.66 ± 2.79 in patients with and without stasis, respectively (P = NS). Stasis occurred in 14 of 81 (17.3%) and 12 of 47 (25.5%) infusions following previous intra-arterial therapy and in therapy-naïve territories, respectively (P = NS). Early stasis occurred in 15 of 41 (36.6%) left, 10 of 65 (15.4%) right and one of 22 (4.5%) whole liver infusions (P < 0.001). Rates of partial response and stable disease were similar in the stasis (88.3%) and non-stasis (76.0%) groups (P = NS). CONCLUSIONS: Early stasis occurred in approximately 20% of infusions with similar incidences in hyper- and hypovascular tumours. Whole-liver therapy reduced the incidence of stasis. Stasis did not appear to affect initial imaging outcomes.
Authors: Kent Sato; Robert J Lewandowski; James T Bui; Reed Omary; Russell D Hunter; Laura Kulik; Mary Mulcahy; David Liu; Howard Chrisman; Scott Resnick; Albert A Nemcek; Robert Vogelzang; Riad Salem Journal: Cardiovasc Intervent Radiol Date: 2006 Jul-Aug Impact factor: 2.740
Authors: Jean-Nicolas Vauthey; Timothy M Pawlik; Dario Ribero; Tsung-Teh Wu; Daria Zorzi; Paulo M Hoff; Henry Q Xiong; Cathy Eng; Gregory Y Lauwers; Mari Mino-Kenudson; Mauro Risio; Andrea Muratore; Lorenzo Capussotti; Steven A Curley; Eddie K Abdalla Journal: J Clin Oncol Date: 2006-05-01 Impact factor: 44.544
Authors: Ravi Murthy; Henry Xiong; Rodolfo Nunez; Alan C Cohen; Bruce Barron; Janio Szklaruk; David C Madoff; Sanjay Gupta; Michael J Wallace; Kamran Ahrar; Marshall E Hicks Journal: J Vasc Interv Radiol Date: 2005-07 Impact factor: 3.464
Authors: Peachy Mae Piana; Carin F Gonsalves; Takami Sato; P Rani Anne; Jeffrey W McCann; Voichita Bar Ad; David J Eschelman; Laurence Parker; Laura A Doyle; Daniel B Brown Journal: J Vasc Interv Radiol Date: 2011-07-20 Impact factor: 3.464
Authors: Frank H Miller; Ana L Keppke; Denise Reddy; Jie Huang; Jianhua Jin; Mary F Mulcahy; Riad Salem Journal: AJR Am J Roentgenol Date: 2007-03 Impact factor: 3.959
Authors: Ana L Keppke; Riad Salem; Denise Reddy; Jie Huang; Jianhua Jin; Andrew C Larson; Frank H Miller Journal: AJR Am J Roentgenol Date: 2007-03 Impact factor: 3.959
Authors: Andrew Kennedy; Subir Nag; Riad Salem; Ravi Murthy; Alexander J McEwan; Charles Nutting; Al Benson; Joseph Espat; Jose Ignacio Bilbao; Ricky A Sharma; James P Thomas; Douglas Coldwell Journal: Int J Radiat Oncol Biol Phys Date: 2007-05-01 Impact factor: 7.038
Authors: Ravi Murthy; Daniel B Brown; Riad Salem; Steven G Meranze; Douglas M Coldwell; Sunil Krishnan; Rodolfo Nunez; Amit Habbu; David Liu; William Ross; Alan M Cohen; Michael Censullo Journal: J Vasc Interv Radiol Date: 2007-04 Impact factor: 3.464
Authors: Mary Ellen Koran; Samantha Stewart; Jennifer C Baker; Andrew J Lipnik; Fil Banovac; Reed A Omary; Daniel B Brown Journal: Biomed Rep Date: 2016-11-01
Authors: I Kurilova; R G H Beets-Tan; G A Ulaner; F E Boas; E N Petre; H Yarmohammadi; E Ziv; A R Deipolyi; L A Brody; M Gonen; Constantinos T Sofocleous Journal: Cardiovasc Intervent Radiol Date: 2018-05-15 Impact factor: 2.740
Authors: Claus Christian Pieper; Winfried A Willinek; Daniel Thomas; Hojjat Ahmadzadehfar; Markus Essler; Jennifer Nadal; Kai E Wilhelm; Hans Heinz Schild; Carsten Meyer Journal: Eur Radiol Date: 2015-11-11 Impact factor: 5.315
Authors: Robert Drescher; Philipp Seifert; Falk Gühne; René Aschenbach; Christian Kühnel; Martin Freesmeyer Journal: J Endovasc Ther Date: 2021-02-25 Impact factor: 3.487